Skip to main content
Veterinary Medicines

Versican Plus P lyophilisate and solvent for suspension for injection for dogs

Authorised
  • Canine parvovirus 2b, strain CPV-2b Bio 12/B, Live

Product identification

Medicine name:
Versican Plus P lyophilisate and solvent for suspension for injection for dogs
Versican Plus P Lyophilisat und Lösungsmittel zur Herstellung einer Injektionssuspension für Hunde
Active substance:
  • Canine parvovirus 2b, strain CPV-2b Bio 12/B, Live
Target species:
  • Dog
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Canine parvovirus 2b, strain CPV-2b Bio 12/B, Live
    19953.00
    tissue culture infective dose 50
    /
    1.00
    Dose
Pharmaceutical form:
  • Lyophilisate and solvent for suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI07AD01
Authorisation status:
  • Valid
Authorised in:
  • Germany
Package description:
  • (ID2): 1 Box with 50 Vial (Glass) with 1 Dose and 50 Vial (Glass) with 1 ml (50.0 Dose, 50.0ml)
  • (ID1): 1 Box with 25 Vial (Glass) with 1 Dose and 25 Vial (Glass) with 1 ml (25.0 Dose, 25.0 ml)

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Zoetis Deutschland GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Bioveta, a.s.
Responsible authority:
  • Paul-Ehrlich-Institut
Authorisation number:
  • PEI.V.11781.01.1
Date of authorisation status change:
Reference member state:
  • Germany
Procedure number:
  • DE/V/0265/001
Concerned member states:
  • Belgium
  • Bulgaria
  • Croatia
  • Cyprus
  • France
  • Greece
  • Hungary
  • Ireland
  • Italy
  • Luxembourg
  • Malta
  • Romania
  • Slovenia
  • United Kingdom (Northern Ireland)

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 18/09/2024

2613561-paren-20170427.pdf.pdf

English (PDF)
Published on: 18/09/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."